The main hypothesis proposes that insulin resistance, obesity, and the metabolic syndrome increase plasminogen activator inhibitor (PAI) levels, conducting to a decreased fibrinolytic state (blockage of thrombus formation) [14,52,53]. The gene discussed is SERPINB2; the disease is obesity disorder.